Crossmark

Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis

Published Online: 2018-08-28

Published Print: 2018-10

Authors

Cai, Xiaoling

Gao, Xueying

Yang, Wenjia

Han, Xueyao

Ji, Linong https://orcid.org/0000-0002-3262-2168
Funding

Funding for this research was provided by:

AstraZeneca Ltd. (meta-analysis)

Foundation for the Author of National Excellent Doctoral Dissertation of the People's Republic of China (2016YFC1304901)
License Information

Text and Data Mining valid from 2018-08-28

Version of Record valid from 2018-08-28
More Information

Article History

Received: 25 July 2018

First Online: 28 August 2018

Document is current